Ampulse Corporation, a developer and manufacturer of solar cell solutions based on proprietary and patented crystalline-silicon (c-Si) thin-film technology, today announced it has closed an $8 million Series A funding co-led by Globespan Capital Partners and El Dorado Ventures, and joined by existing investors Battelle Ventures and its affiliate fund, Innovation Valley Partners.
NanoLogix, Inc. announces that the company has recently filed BNP (BioNanoPore) national patent applications in China, Japan, India, Brazil, Russia and the EU. These applications were filed in order to obtain intellectual property protection for the company's technology in countries viewed as representing the largest potential international market for BNP rapid detection, a revolutionary sandwiched-membrane Petri-based technology that can reduce microorganism detection times by 100-400%.
Marco Beckmann, CEO of Nanostart AG, the global nanotechnology investment company based in Frankfurt, will be presenting the company and its portfolio holdings to an audience of approx. 80 selected investors and analysts on November 5 in New York City's Manhattan Club.
Novellus Systems announced today that it has developed a new tungsten deposition process, called LRWxT, that can effectively reduce contact and line resistance at the 3Xnm technology node compared to conventional tungsten chemical vapor deposition (CVD-W) technology.
Ultratech, Inc., a leading supplier of lithography and laser-processing systems used to manufacture semiconductor devices, today announced that it has received a follow-on order for its AP200 lithography system, which features an innovative dual-side alignment (DSA) system for through-silicon via (TSV) applications.
As well as presenting a technical paper and exhibiting from its range of Zetasizer light scattering solutions and Viscotek size exclusion chromatography systems, Malvern Instruments is sponsoring the 'Protein Aggregation' track at the next Cambridge Healthtech Institute PepTalk conference (January 11-15, 2010, San Diego, California).
Nanocomp Technologies, Inc. today announced it has been awarded an extension to its existing development contract with the U.S. Army Natick Soldier Systems Center in Massachusetts. The new contract modifies one signed in August 2008 between the parties to develop carbon nanotube materials for the purpose of improving body armor.
MagForce Nanotechnologies AG, the Berlin-based medical technology company, today announced the successful completion of final clinical trials demonstrating the efficacy of its Nano-Cancer therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective.
Die Nanostart-Tochter MagForce Nanotechnologies AG hat heute bekannt gegeben, dass die Wirksamkeitsstudie der Nano-Krebs-Therapie bei Patienten mit Glioblastom-Rezidiv, einem haeufigen, boesartigen Hirntumor, erfolgreich abgeschlossen wurde. Die Ergebnisse zeigen, dass das Studienziel dabei deutlich uebertroffen werden konnte.
Cambridge Research and Instrumentation, Inc. (CRi), a leader in biomedical imaging, today announced the launch of inForm, advanced image analysis software based on the company's proprietary Machine Learning System.
Nanometrics Incorporated, a leading supplier of advanced process control metrology systems used primarily in the manufacturing and packaging of semiconductors, solar photovoltaics and high-brightness LEDs, today announced a multi-system order from a leading semiconductor foundry for its Integrated Metrology and NanoCD suite solutions.